VYGR

Voyager Therapeutics, Inc. Common Stock

4.00

USD

VYGR Earnings Reports

Positive Surprise Ratio

VYGR beat 24 of 40 last estimates.

60%

Next Report

Date of Next Report

Mar 09, 2026

Estimate for Q4 25 (Revenue/ EPS)

$10.70M

-$0.52

Implied change from Q3 25 (Revenue/ EPS)

-19.95%

+10.64%

Implied change from Q4 24 (Revenue/ EPS)

+70.41%

-11.86%

Voyager Therapeutics, Inc. Common Stock earnings per share and revenue

On Nov 10, 2025, VYGR reported earnings of -0.47 USD per share (EPS) for Q3 25, beating the estimate of -0.53 USD, resulting in a 11.45% surprise. Revenue reached 13.37 million, compared to an expected 8.02 million, with a 66.74% difference. The market reacted with a +0.71% price change (close before vs. close after earnings).

Looking ahead to Q4 25, 14 analysts forecast an EPS of -0.52 USD, with revenue projected to reach 10.70 million USD, implying an increase of 10.64% EPS, and decrease of -19.95% in Revenue from the last quarter.

Industry Peers’ Earnings

Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.

Nurix Therapeutics, Inc. Common stock

Report Date

Jan 28, 2026 For Q4 25

Estimate

-$0.88

Actual

-$0.82

Surprise

+7.66%

Regeneron Pharmaceuticals Inc

Report Date

Jan 30, 2026 For Q4 25

Estimate

$10.84

Actual

$11.44

Surprise

+5.52%

Twist Bioscience Corporation Common Stock

Report Date

Feb 02, 2026 For Q1 26

Estimate

-$0.43

Actual

-$0.50

Surprise

-14.00%

FAQ

What were Voyager Therapeutics, Inc. Common Stock's earnings and revenue for the latest quarter Q3 2025?

For Q3 2025, Voyager Therapeutics, Inc. Common Stock reported EPS of -$0.47, beating estimates by 11.45%, and revenue of $13.37M, 66.74% above expectations.

How did the market react to Voyager Therapeutics, Inc. Common Stock's Q3 2025 earnings?

The stock price moved up 0.71%, changed from $4.23 before the earnings release to $4.26 the day after.

When is Voyager Therapeutics, Inc. Common Stock expected to report next?

The next earning report is scheduled for Mar 09, 2026.

What are the forecasts for Voyager Therapeutics, Inc. Common Stock's next earnings report?

Based on 14 analysts, Voyager Therapeutics, Inc. Common Stock is expected to report EPS of -$0.52 and revenue of $10.70M for Q4 2025.

Which companies are reporting earnings today?

Check FXEmpire's Earnings Calendar for today's list of reporting companies.